Відмінності між версіями «Atients with visual impairment had a higher prevalence of DM and»
Матеріал з HistoryPedia
м |
м |
||
Рядок 1: | Рядок 1: | ||
− | + | Atients with visual [http://www.medchemexpress.com/ZL006.html ZL006 biological activity] impairment had a higher prevalence of DM and cardiovascular [http://www.medchemexpress.com/L-Threonine,_N-[[[_1S_-3-amino-1-[3-[_1R_-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl]amino]carbonyl]-.html PD-1-IN-1 cost] disease than [http://www.medchemexpress.com/Elacestrant.html Elacestrant dose] [http://www.medchemexpress.com/Emixustat.html Emixustat web] patients [http://www.medchemexpress.com/ZL006.html ZL006 price] without visual impairment. In the multivariable logistic analysis, the comorbid condition of DM was the most significant risk factor for visual impairment (odds ratio [OR] 2.777, 95 confidence interval [CI] 2.170?.553, P |
Версія за 16:38, 16 березня 2018
Atients with visual ZL006 biological activity impairment had a higher prevalence of DM and cardiovascular [[[_1S_-3-amino-1-[3-[_1R_-1-amino-2-hydroxyethyl-1,2,4-oxadiazol-5-yl]-3-oxopropyl]amino]carbonyl]-.html PD-1-IN-1 cost] disease than Elacestrant dose Emixustat web patients ZL006 price without visual impairment. In the multivariable logistic analysis, the comorbid condition of DM was the most significant risk factor for visual impairment (odds ratio [OR] 2.777, 95 confidence interval [CI] 2.170?.553, P